Syntheses and Antibacterial Studies of Some 1-Phenyl-3-(4-(2-ethanoloxy) phenyl)-5-aryl-1H-pyrazoles

Table 1

In vitro antibacterial activity of 1-phenyl-3-(4-(2-ethanoloxy) phenyl)-5-aryl-1𝐻-pyrazoles (3a–g).

Compound	Minimum inhibitory concentration (μg/mL)
	B. subtilis	S. aureus	E. coli	P. aeruginosa
	(MTCC 121)	(MTCC 96)	(MTCC 40)	(MTCC 2453)
3a	0.50	0.50	0.40	0.45
3b	0.50	0.50	0.40	0.45
3c	0.55	0.55	0.45	0.50
3d	0.45	0.45	0.30	0.40
3e	0.45	0.45	0.30	0.40
3f	0.45	0.45	0.30	0.40
3g	0.40	0.45	0.30	0.35
Ciprofloxacin (standard drug)	0.12	0.15	0.01	0.25